Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
130.7 USD | 0.00% | +3.53% | +14.26% |
Apr. 22 | RBC Capital Adjusts Xylem Price Target to $157 From $153 | MT |
Apr. 18 | Oppenheimer Adjusts Price Target on Xylem to $142 From $133, Outperform Rating Kept | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 38.83 times its estimated earnings per share for the ongoing year.
- With an enterprise value anticipated at 3.8 times the sales for the current fiscal year, the company turns out to be overvalued.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is highly valued given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Industrial Machinery & Equipment
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+14.26% | 31.59B | A | ||
+8.35% | 82.5B | A- | ||
+18.59% | 70.16B | B | ||
+19.60% | 37.32B | B- | ||
+3.29% | 26.77B | C+ | ||
+7.43% | 28.13B | B- | ||
+3.35% | 26.3B | B+ | ||
+14.45% | 24.99B | B+ | ||
+11.46% | 23.55B | B | ||
+8.40% | 16.48B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- XYL Stock
- Ratings Xylem Inc.